LogicBio Therapeutics Inc

NASDAQ:LOGC   3:59:51 PM EDT
4.73
+0.07 (+1.50%)
Products, Strategic Combinations

LogicBio Therapeutics Announces Research Collaboration With Daiichi Sankyo

Published: 04/27/2021 12:14 GMT
LogicBio Therapeutics Inc (LOGC) - Logicbio Therapeutics Announces Research Collaboration With Daiichi Sankyo.
Logicbio Therapeutics Inc - Financial Terms of Collaboration Are Not Disclosed.
Logicbio Therapeutics - Agreement Grants Daiichi Sankyo Option to Negotiate & Acquire Worldwide Licenses for Logicbio's Development Programs in 2 Indications.
Logicbio Therapeutics Inc - Companies Will Collaborate on Development of Treatments for 2 Undisclosed Indications Based on Generide.